Clinical Trial Update: Irbesartan Effects on Endothelial Dysfunction in Hypertensive Type II Diabetic Patients Comparing Atenolol [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the effects of irbesartan on endothelial dysfunction in hypertensive patients with type 2 diabetes, using atenolol as c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• Atenolol (Atenolol)
• Irbesartan (irbesartan)

Snippet

Sponsor: Sanofi | Conditions: Hypertension, Diabetes Mellitus Type 2 | Phase 4 | Status: COMPLETED